Polyvalent vaccination against hepatitis B surface and core antigen using a dicistronic expression plasmid

By Wild J.   Gruner B.   Metzger K.   Kuhrober A.   Pudollek H.-P.   Hauser H.   Schirmbeck R.   Reimann J.  

Vaccine, Vol. 16, Iss. 4, 1998-02 ,pp. : 353-360

Elsevier

Access to resources Recommend Favorite

An effective intradermal hepatitis B vaccination

By Yamashiki M.   Kosaka Y.   Nishimura A.  

Vaccine, Vol. 15, Iss. 15, 1997-10 ,pp. : 1618-1623

Elsevier

Access to resources Recommend Favorite

Vaccination with plasmid DNA expressing antigen from genomic or cDNA gene forms induces equivalent humoral immune responses

By Drew D.R.   Lightowlers M.   Strugnell R.A.  

Vaccine, Vol. 18, Iss. 7, 1999-11 ,pp. : 692-702

Elsevier

Access to resources Recommend Favorite

Yeast expressing hepatitis B virus surface antigen determinants on its surface: implications for a possible oral vaccine

By Schreuder M.P.   Deen C.   Boersma W.J.A.   Pouwels P.H.   Klis F.M.  

Vaccine, Vol. 14, Iss. 5, 1996-04 ,pp. : 383-388

Elsevier

Access to resources Recommend Favorite

Immunization with a plasmid encoding a modified hepatitis B surface antigen carrying the receptor binding site for hepatocytes

By Hui J.   Mancini M.   Li G.   Wang Y.   Tiollais P.   Michel M.-L.  

Vaccine, Vol. 17, Iss. 13, 1999-01 ,pp. : 1711-1718

Elsevier

Access to resources Recommend Favorite